$IRTC
iRhythm Technologies, Inc.

2017 Q1 Form 10-K Financial Statement

#000156459017005767 Filed on March 31, 2017

View on sec.gov

Income Statement

Concept 2017 Q1 2016 Q4 2016
Revenue $21.44M $18.70M $64.07M
YoY Change 66.77% 72.32% 77.29%
Cost Of Revenue $6.340M $5.790M $20.88M
YoY Change 36.05% 39.18% 42.06%
Gross Profit $15.10M $12.92M $43.19M
YoY Change 84.26% 93.01% 101.44%
Gross Profit Margin 70.44% 69.07% 67.41%
Selling, General & Admin $17.22M $14.96M $51.62M
YoY Change 49.48% 26.89% 40.57%
% of Gross Profit 114.04% 115.81% 119.52%
Research & Development $2.620M $2.300M $7.150M
YoY Change 69.03% 27.78% 12.62%
% of Gross Profit 17.35% 17.8% 16.56%
Depreciation & Amortization $300.0K -$80.00K $570.0K
YoY Change 30.43% -140.0% 16.33%
% of Gross Profit 1.99% -0.62% 1.32%
Operating Expenses $19.84M $17.26M $58.77M
YoY Change 51.8% 27.01% 36.45%
Operating Profit -$4.740M -$4.342M -$15.58M
YoY Change -2.77% -37.05% -27.96%
Interest Expense -$820.0K -$860.0K $3.248M
YoY Change 2.5% 48.28% 206.7%
% of Operating Profit
Other Income/Expense, Net $260.0K $3.700M -$2.073M
YoY Change -156.52% -1708.7% 1801.83%
Pretax Income -$5.300M -$6.270M -$20.90M
YoY Change -13.54% -18.57% -8.32%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$5.303M -$6.266M -$20.90M
YoY Change -13.43% -18.64% -8.32%
Net Earnings / Revenue -24.74% -33.5% -32.62%
Basic Earnings Per Share
Diluted Earnings Per Share -$239.3K -$374.1K -$3.943M
COMMON SHARES
Basic Shares Outstanding 22.15M 22.13M
Diluted Shares Outstanding

Balance Sheet

Concept 2017 Q1 2016 Q4 2016
SHORT-TERM ASSETS
Cash & Short-Term Investments $93.00M $106.1M $106.1M
YoY Change 321.03% 321.03%
Cash & Equivalents $15.58M $51.64M $51.60M
Short-Term Investments $77.40M $54.40M $54.40M
Other Short-Term Assets $1.500M $1.800M $1.800M
YoY Change 100.0% 100.0%
Inventory $1.200M $1.390M $1.400M
Prepaid Expenses
Receivables $11.00M $9.406M $9.400M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $106.6M $118.6M $118.6M
YoY Change 261.29% 261.59%
LONG-TERM ASSETS
Property, Plant & Equipment $5.529M $4.653M $4.700M
YoY Change 128.54% 135.0%
Goodwill $862.0K
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments $16.40M $11.00M $11.00M
YoY Change
Other Assets $3.400M $3.052M $3.100M
YoY Change 42.28% 47.62%
Total Long-Term Assets $26.20M $19.55M $19.60M
YoY Change 287.63% 284.31%
TOTAL ASSETS
Total Short-Term Assets $106.6M $118.6M $118.6M
Total Long-Term Assets $26.20M $19.55M $19.60M
Total Assets $132.8M $138.2M $138.2M
YoY Change 264.8% 264.64%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.400M $2.103M $2.100M
YoY Change 44.14% 40.0%
Accrued Expenses $8.300M $10.17M $10.20M
YoY Change 51.74% 50.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $10.68M $13.22M $13.20M
YoY Change 50.6% 50.0%
LONG-TERM LIABILITIES
Long-Term Debt $32.65M $32.23M $32.20M
YoY Change 5.48% 5.23%
Other Long-Term Liabilities $200.0K $200.0K $200.0K
YoY Change -93.55% -93.55%
Total Long-Term Liabilities $32.65M $32.23M $32.40M
YoY Change 5.48% -3.86%
TOTAL LIABILITIES
Total Short-Term Liabilities $10.68M $13.22M $13.20M
Total Long-Term Liabilities $32.65M $32.23M $32.40M
Total Liabilities $43.33M $45.59M $45.60M
YoY Change 7.53% 7.55%
SHAREHOLDERS EQUITY
Retained Earnings -$127.2M
YoY Change 19.67%
Common Stock $219.7M
YoY Change 4633.74%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $89.30M $93.04M $92.60M
YoY Change
Total Liabilities & Shareholders Equity $132.8M $138.2M $138.2M
YoY Change 264.8% 264.64%

Cashflow Statement

Concept 2017 Q1 2016 Q4 2016
OPERATING ACTIVITIES
Net Income -$5.303M -$6.266M -$20.90M
YoY Change -13.43% -18.64% -8.32%
Depreciation, Depletion And Amortization $300.0K -$80.00K $570.0K
YoY Change 30.43% -140.0% 16.33%
Cash From Operating Activities -$6.400M -$940.0K -$16.65M
YoY Change -32.56% -83.21% -7.55%
INVESTING ACTIVITIES
Capital Expenditures $1.174M -$940.0K $2.763M
YoY Change 78.15% 248.15% 54.62%
Acquisitions
YoY Change
Other Investing Activities -$28.52M -$65.40M -$65.40M
YoY Change
Cash From Investing Activities -$29.70M -$66.35M -$68.17M
YoY Change 4400.0% 24474.07% 3708.16%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $35.00K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 40.00K 113.2M 111.3M
YoY Change -104.88% 372.68% 205.81%
NET CHANGE
Cash From Operating Activities -6.400M -940.0K -16.65M
Cash From Investing Activities -29.70M -66.35M -68.17M
Cash From Financing Activities 40.00K 113.2M 111.3M
Net Change In Cash -36.06M 45.87M 26.44M
YoY Change 228.71% 153.85% 59.44%
FREE CASH FLOW
Cash From Operating Activities -$6.400M -$940.0K -$16.65M
Capital Expenditures $1.174M -$940.0K $2.763M
Free Cash Flow -$7.574M $0.00 -$19.41M
YoY Change -25.37% -100.0% -1.93%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q4 us-gaap Short Term Investments
ShortTermInvestments
54407000
CY2016Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
9406000
CY2015Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5577000
CY2016Q4 us-gaap Inventory Net
InventoryNet
1390000
CY2015Q4 us-gaap Inventory Net
InventoryNet
1145000
CY2016Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1671000
CY2015Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
808000
CY2016Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
91000
CY2016Q4 us-gaap Available For Sale Securities Noncurrent
AvailableForSaleSecuritiesNoncurrent
10981000
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4653000
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2036000
CY2016Q4 us-gaap Goodwill
Goodwill
862000
CY2015Q4 us-gaap Interest Payable Current
InterestPayableCurrent
111000
CY2016 dei Document Type
DocumentType
10-K
CY2016 dei Amendment Flag
AmendmentFlag
false
CY2016 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2016
CY2016 dei Trading Symbol
TradingSymbol
IRTC
CY2016 dei Entity Registrant Name
EntityRegistrantName
iRhythm Technologies, Inc.
CY2016 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2016 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2016 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2016 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2017Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
22152637
CY2016Q2 dei Entity Public Float
EntityPublicFloat
314000000
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
51643000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
25208000
CY2015Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
91000
CY2016Q4 us-gaap Assets Current
AssetsCurrent
118608000
CY2015Q4 us-gaap Goodwill
Goodwill
862000
CY2016Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3052000
CY2015Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2145000
CY2016Q4 us-gaap Assets
Assets
138156000
CY2015Q4 us-gaap Assets
Assets
37872000
CY2016Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2103000
CY2015Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1459000
CY2016Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
10165000
CY2015Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6699000
CY2016Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
947000
CY2015Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
506000
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
13215000
CY2016Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
32227000
CY2016Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
26000
CY2016Q4 irtc Accrued Interest Non Current
AccruedInterestNonCurrent
126000
CY2015Q4 irtc Preferred Stock Warrant Liabilities
PreferredStockWarrantLiabilities
2949000
CY2015Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
97096000
CY2015Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
1000
CY2015Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
4641000
CY2016Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-9000
CY2015Q4 us-gaap Assets Current
AssetsCurrent
32829000
CY2016 dei Document Period End Date
DocumentPeriodEndDate
2016-12-31
CY2016 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2015Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
92562000
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
-101624000
CY2015Q4 us-gaap Liabilities
Liabilities
42400000
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
37872000
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
138156000
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
22000
CY2016Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
219718000
CY2016 us-gaap Gross Profit
GrossProfit
43189000
CY2016 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
51621000
CY2015 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
36722000
CY2014 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
20225000
CY2015 us-gaap Operating Expenses
OperatingExpenses
43071000
CY2014 us-gaap Operating Expenses
OperatingExpenses
25923000
CY2014 us-gaap Operating Income Loss
OperatingIncomeLoss
-14765000
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
8775000
CY2015Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
30552000
CY2015Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
28000
CY2015Q4 irtc Accrued Interest Non Current
AccruedInterestNonCurrent
96000
CY2016Q4 us-gaap Liabilities
Liabilities
45594000
CY2016 dei Entity Central Index Key
EntityCentralIndexKey
0001388658
CY2016 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2016 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-20912000
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
-65590000
CY2016 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-6000
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-127169000
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-106266000
CY2014 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-15832000
CY2015 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-22799000
CY2016Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2015Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2015Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
0
CY2016Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2015Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2016Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2015Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
18528913
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
22139346
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1410565
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
22139346
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1410565
CY2016 us-gaap Sales Revenue Net
SalesRevenueNet
64072000
CY2015 us-gaap Sales Revenue Net
SalesRevenueNet
36140000
CY2014 us-gaap Sales Revenue Net
SalesRevenueNet
21749000
CY2016 us-gaap Cost Of Revenue
CostOfRevenue
20883000
CY2015 us-gaap Cost Of Revenue
CostOfRevenue
14700000
CY2014 us-gaap Cost Of Revenue
CostOfRevenue
10591000
CY2015 us-gaap Gross Profit
GrossProfit
21440000
CY2014 us-gaap Gross Profit
GrossProfit
11158000
CY2016 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7150000
CY2015 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6349000
CY2014 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5698000
CY2016 us-gaap Operating Expenses
OperatingExpenses
58771000
CY2016 us-gaap Operating Income Loss
OperatingIncomeLoss
-15582000
CY2015 us-gaap Operating Income Loss
OperatingIncomeLoss
-21631000
CY2016 us-gaap Interest Expense
InterestExpense
3248000
CY2015 us-gaap Interest Expense
InterestExpense
1059000
CY2014 us-gaap Interest Expense
InterestExpense
774000
CY2016 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2073000
CY2015 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-109000
CY2014 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-293000
CY2016 us-gaap Net Income Loss
NetIncomeLoss
-20903000
CY2015 us-gaap Net Income Loss
NetIncomeLoss
-22799000
CY2014 us-gaap Net Income Loss
NetIncomeLoss
-15832000
CY2016 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-3.95
CY2015 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-16.57
CY2014 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-12.05
CY2016 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5285847
CY2015 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1376106
CY2014 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1314294
CY2016 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-9000
CY2014 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
50000
CY2014 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
828000
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
-80544000
CY2015 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
309000
CY2015 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1410000
CY2016 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
132000
CY2016 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
110721000
CY2016 irtc Adjustments To Additional Paid In Capital Conversion Of Convertible Preferred Stock Warrants To Common Stock Warrants In Connection With Initial Public Offering
AdjustmentsToAdditionalPaidInCapitalConversionOfConvertiblePreferredStockWarrantsToCommonStockWarrantsInConnectionWithInitialPublicOffering
4821000
CY2016 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1871000
CY2016 us-gaap Depreciation And Amortization
DepreciationAndAmortization
568000
CY2015 us-gaap Depreciation And Amortization
DepreciationAndAmortization
492000
CY2014 us-gaap Depreciation And Amortization
DepreciationAndAmortization
242000
CY2016 us-gaap Share Based Compensation
ShareBasedCompensation
1871000
CY2015 us-gaap Share Based Compensation
ShareBasedCompensation
1410000
CY2014 us-gaap Share Based Compensation
ShareBasedCompensation
828000
CY2016 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
251000
CY2015 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
116000
CY2014 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
111000
CY2016 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-16651000
CY2015 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-18005000
CY2014 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-15626000
CY2016 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2763000
CY2015 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-10000
CY2014 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-7000
CY2015 irtc Increase Decrease In Accrued Interest
IncreaseDecreaseInAccruedInterest
-64000
CY2014 irtc Increase Decrease In Accrued Interest
IncreaseDecreaseInAccruedInterest
-89000
CY2016 irtc Provision For Bad Debt And Contractual Allowance
ProvisionForBadDebtAndContractualAllowance
4686000
CY2015 irtc Provision For Bad Debt And Contractual Allowance
ProvisionForBadDebtAndContractualAllowance
1557000
CY2014 irtc Provision For Bad Debt And Contractual Allowance
ProvisionForBadDebtAndContractualAllowance
401000
CY2016 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
2123000
CY2015 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
111000
CY2014 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
291000
CY2016 us-gaap Paid In Kind Interest
PaidInKindInterest
1481000
CY2016 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
8515000
CY2015 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1281000
CY2014 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2565000
CY2016 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
245000
CY2015 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
327000
CY2014 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
71000
CY2016 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
863000
CY2015 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
506000
CY2014 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
35000
CY2016 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
1235000
CY2015 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
491000
CY2014 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
1166000
CY2016 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
305000
CY2015 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
132000
CY2014 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
703000
CY2016 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
3380000
CY2015 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
3522000
CY2014 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1399000
CY2016 irtc Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
-2000
CY2015 irtc Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
28000
CY2014 irtc Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
-28000
CY2016 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
441000
CY2015 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
85000
CY2014 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
178000
CY2015 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1787000
CY2014 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
539000
CY2016 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
65403000
CY2016 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-68166000
CY2015 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-1787000
CY2014 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-539000
CY2016 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
132000
CY2015 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
309000
CY2014 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
50000
CY2016 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
206000
CY2015 us-gaap Proceeds From Issuance Of Redeemable Convertible Preferred Stock
ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
12134000
CY2014 us-gaap Proceeds From Issuance Of Redeemable Convertible Preferred Stock
ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
17229000
CY2016 irtc Payments Of Deferred Offering Costs
PaymentsOfDeferredOfferingCosts
3522000
CY2015 irtc Payments Of Deferred Offering Costs
PaymentsOfDeferredOfferingCosts
5000
CY2015 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
29018000
CY2014 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
4905000
CY2015 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
4905000
CY2014 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
4500000
CY2015Q4 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
1254000
CY2015Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
1254000
CY2016 irtc Stock Issuance Costs Incurred But Not Yet Paid
StockIssuanceCostsIncurredButNotYetPaid
188000
CY2016 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
114436000
CY2016 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
111252000
CY2015 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
36382000
CY2014 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
17684000
CY2015 irtc Stock Issuance Costs Incurred But Not Yet Paid
StockIssuanceCostsIncurredButNotYetPaid
265000
CY2016 us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
26435000
CY2015 us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
16590000
CY2014 us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
1519000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8618000
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7099000
CY2016 us-gaap Interest Paid
InterestPaid
1591000
CY2015 us-gaap Interest Paid
InterestPaid
343000
CY2014 us-gaap Interest Paid
InterestPaid
318000
CY2015 irtc Issuance Of Warrants To Purchase Preferred Stock
IssuanceOfWarrantsToPurchasePreferredStock
44000
CY2014 irtc Issuance Of Warrants To Purchase Preferred Stock
IssuanceOfWarrantsToPurchasePreferredStock
98000
CY2016 irtc Property And Equipment Included In Accounts Payable
PropertyAndEquipmentIncludedInAccountsPayable
423000
CY2016 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
97553000
CY2016 irtc Conversion Of Preferred Stock Warrants To Common Stock Warrants
ConversionOfPreferredStockWarrantsToCommonStockWarrants
4821000
CY2016 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:5.24%;">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. On an ongoing basis, management evaluates its estimates, including those related to revenue recognition, contractual allowances for revenue, allowance for doubtful accounts, the useful lives of property and equipment, the recoverability of long-lived assets including the estimated usage of the printed circuit board assemblies (&#8220;PCBAs&#8221;), the valuation of deferred tax assets, the fair value of the Company&#8217;s preferred and common stock and stock-based compensation. The Company bases these estimates on historical and anticipated results, trends, and various other assumptions that the Company believes are reasonable under the circumstances, including assumptions as to future events. Actual results may differ from those estimates.</p></div>
CY2016 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Credit Risk</p> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:5.24%;">Financial instruments that potentially subject the Company to a concentration of credit risk consist primarily of cash and cash equivalents, investments and accounts receivable. Cash and cash equivalents and investments are deposited with one financial institution in the United States of America. At times, such deposits may be in excess of federally insured limits. Cash equivalents are invested in highly rated money market funds. The Company invests in a variety of financial instruments, such as, but not limited to, United States Government securities, corporate notes, commercial paper and, by policy, limits the amount of credit exposure with any one financial institution or commercial issuer. The Company has not experienced any material losses on its deposits of cash and cash equivalents or investments.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Concentrations of credit risk with respect to accounts receivable are limited due to the large number of customers comprising the Company&#8217;s customer base and their dispersion across many geographies. The Company does not require collateral. The Company records an allowance for doubtful accounts when it becomes probable that a receivable will not be collected. Government agencies, including CMS and the Veterans Administration, accounted for 40%, 41% and 30% of the Company&#8217;s revenue for the years ended December&#160;31, 2016, 2015 and 2014, respectively. Accounts receivable related to federal government agencies accounted for 27% and 30% at December&#160;31, 2016 and 2015, respectively.</p></div>
CY2016 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Reclassification of Prior Year Presentation</p> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain prior year amounts have been reclassified for consistency with the current period presentation. These reclassifications had no effect on the Company&#8217;s results of operations, net loss or cash flows. </p></div>
CY2016 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
On October 4, 2016, the Company’s board of directors approved an amendment to the Company’s amended and restated certificate of incorporation to effect a reverse split of the Company’s issued and outstanding common stock at a 1-for- 5.882698 ratio, which was effected on October 5, 2016.
CY2016Q4 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
5.882698
CY2015Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1125000
CY2014Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
470000
CY2016 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1960000
CY2015 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1177000
CY2016 irtc Allowance For Doubtful Accounts Receivable Write Offs Net Of Recoveries And Other Adjustments
AllowanceForDoubtfulAccountsReceivableWriteOffsNetOfRecoveriesAndOtherAdjustments
1293000
CY2015 irtc Allowance For Doubtful Accounts Receivable Write Offs Net Of Recoveries And Other Adjustments
AllowanceForDoubtfulAccountsReceivableWriteOffsNetOfRecoveriesAndOtherAdjustments
522000
CY2016Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1792000
CY2015Q4 irtc Accounts Receivable For Contractual Allowance
AccountsReceivableForContractualAllowance
338000
CY2014Q4 irtc Accounts Receivable For Contractual Allowance
AccountsReceivableForContractualAllowance
91000
CY2016 irtc Contractual Allowance Before Adjustments
ContractualAllowanceBeforeAdjustments
2726000
CY2015 irtc Contractual Allowance Before Adjustments
ContractualAllowanceBeforeAdjustments
380000
CY2016 irtc Accounts Receivable For Contractual Allowance Write Offs Net Of Recoveries And Other Adjustments
AccountsReceivableForContractualAllowanceWriteOffsNetOfRecoveriesAndOtherAdjustments
724000
CY2015 irtc Accounts Receivable For Contractual Allowance Write Offs Net Of Recoveries And Other Adjustments
AccountsReceivableForContractualAllowanceWriteOffsNetOfRecoveriesAndOtherAdjustments
133000
CY2016Q4 irtc Accounts Receivable For Contractual Allowance
AccountsReceivableForContractualAllowance
2340000
CY2016 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2015Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
300000
CY2016Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
3700000
CY2016 us-gaap Income Tax Examination Likelihood Of Unfavorable Settlement
IncomeTaxExaminationLikelihoodOfUnfavorableSettlement
greater than 50%
CY2016 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2016Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
111334000
CY2016Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
11000
CY2016Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
20000
CY2016Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
111325000
CY2016Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
45937000
CY2016Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
111325000
CY2015Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
1254000
CY2015Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
1254000
CY2015Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
1254000
CY2016 irtc Available For Sale Securities Maturity Period
AvailableForSaleSecuritiesMaturityPeriod
P150D
CY2014 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
281000
CY2016Q4 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
100344000
CY2016Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
111325000
CY2015Q4 us-gaap Financial Liabilities Fair Value Disclosure
FinancialLiabilitiesFairValueDisclosure
2949000
CY2016 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
0
CY2016 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
0
CY2016Q4 irtc Inventory And Printed Circuit Board Assemblies
InventoryAndPrintedCircuitBoardAssemblies
4163000
CY2015Q4 irtc Inventory And Printed Circuit Board Assemblies
InventoryAndPrintedCircuitBoardAssemblies
2776000
CY2016Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
6304000
CY2015Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3119000
CY2016Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1651000
CY2015Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1083000
CY2016Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
1642000
CY2015Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
1250000
CY2016Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
6179000
CY2015Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3838000
CY2016Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
636000
CY2015Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
652000
CY2016Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1708000
CY2015Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
959000
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
4678000
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
4712000
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
4721000
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
782000
CY2016Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
14893000
CY2016 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
3100000
CY2015 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
1600000
CY2014 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
1300000
CY2016Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
1549000
CY2016Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
4858000
CY2016Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
3192000
CY2016Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
19169000
CY2016Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
17564000
CY2016Q4 us-gaap Long Term Debt
LongTermDebt
46332000
CY2016Q4 irtc Debt Instrument Interest Portion
DebtInstrumentInterestPortion
13241000
CY2016Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
-864000
CY2016Q4 irtc Long Term Debt Maturities Repayments Of Principal Present Value Of Minimum Payments
LongTermDebtMaturitiesRepaymentsOfPrincipalPresentValueOfMinimumPayments
32227000
CY2016 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2015 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2014 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2016 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-7107000
CY2015 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-7752000
CY2014 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-5365000
CY2014 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
3000
CY2016 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
255000
CY2015 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
251000
CY2016 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
916000
CY2015 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-128000
CY2014 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
166000
CY2016 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
139000
CY2015 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
178000
CY2014 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
168000
CY2016 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
6075000
CY2015 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
7807000
CY2014 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
5083000
CY2015Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
11046146
CY2015Q4 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
13343981
CY2015Q4 us-gaap Temporary Equity Liquidation Preference
TemporaryEquityLiquidationPreference
117495000
CY2015 us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
97096000
CY2016Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
0
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
382071
CY2016Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
38694000
CY2015Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
34714000
CY2014Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
27318000
CY2016Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
1587000
CY2015Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
1728000
CY2014Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
1388000
CY2016Q4 irtc Deferred Tax Assets Valuation Allowances And Other
DeferredTaxAssetsValuationAllowancesAndOther
4787000
CY2015Q4 irtc Deferred Tax Assets Valuation Allowances And Other
DeferredTaxAssetsValuationAllowancesAndOther
2024000
CY2014Q4 irtc Deferred Tax Assets Valuation Allowances And Other
DeferredTaxAssetsValuationAllowancesAndOther
807000
CY2016Q4 irtc Deferred Tax Assets Liabilities Depreciation And Amortization
DeferredTaxAssetsLiabilitiesDepreciationAndAmortization
-207000
CY2015Q4 irtc Deferred Tax Assets Liabilities Depreciation And Amortization
DeferredTaxAssetsLiabilitiesDepreciationAndAmortization
99000
CY2014Q4 irtc Deferred Tax Assets Liabilities Depreciation And Amortization
DeferredTaxAssetsLiabilitiesDepreciationAndAmortization
357000
CY2016Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
44861000
CY2015Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
38565000
CY2014Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
29870000
CY2016Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
44861000
CY2015Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
38565000
CY2014Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
29870000
CY2016Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
CY2015Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
CY2014Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
CY2016Q4 irtc Operating Loss Carryforwards Tax Benefit Recognized
OperatingLossCarryforwardsTaxBenefitRecognized
0
CY2016Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
0
CY2016Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
104600000
CY2016Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
58600000
CY2016Q4 us-gaap Tax Credit Carryforward Amount
TaxCreditCarryforwardAmount
1300000
CY2016Q4 us-gaap Tax Credit Carryforward Valuation Allowance
TaxCreditCarryforwardValuationAllowance
1200000
CY2016 irtc Tax Credit Carryforwards Expiration Start Year
TaxCreditCarryforwardsExpirationStartYear
2027
CY2015Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
570000
CY2014Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
460000
CY2013Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
364000
CY2016 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
75000
CY2015 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
110000
CY2014 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
96000
CY2016 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
29000
CY2016Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
616000
CY2016Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2015Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2016 us-gaap Dividends Common Stock
DividendsCommonStock
0
CY2016Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
7526060
CY2015Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
16689946
CY2015Q4 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
11392882
CY2015Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
11046146
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
356979
CY2014 irtc Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant Granted In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGrantedInPeriod
429474
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
38238
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
347814
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
781954
CY2015 irtc Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant Granted In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGrantedInPeriod
915080
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
117250
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
331938
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
3865000
CY2016 irtc Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant Granted In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantGrantedInPeriod
466914
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
13013
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
3743037
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1620129
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
429474
CY2014 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
38982
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1972383
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
915080
CY2015 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
84300
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2685913
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
361385
CY2016 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
57067
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2977218
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1940798
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
2912854
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.59
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
3.86
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.30
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
3.34
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.70
CY2015 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
3.98
CY2015 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
3.71
CY2015 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
3.94
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.81
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
15.65
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.33
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
6.92
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.16
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
4.35
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
6.06
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y2M12D
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y10M10D
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y7M17D
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y11M5D
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y3M
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P7Y22D
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
4191000
CY2015Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
11589000
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
70979000
CY2016Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
49775000
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
69746000
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
8.76
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.08
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.20
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
654000
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
237000
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
96000
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
1800000
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
1100000
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
869000
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y1M6D
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y1M6D
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y1M6D
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.600
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.600
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.600
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0142
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0176
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0208
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000
CY2016 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1871000
CY2015 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1410000
CY2014 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
828000
CY2016Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
5100000
CY2016 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y10M24D
CY2016 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3299992
CY2015 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
16358008
CY2016Q1 us-gaap Sales Revenue Net
SalesRevenueNet
12854000
CY2016Q2 us-gaap Sales Revenue Net
SalesRevenueNet
15734000
CY2016Q3 us-gaap Sales Revenue Net
SalesRevenueNet
16780000
CY2016Q4 us-gaap Sales Revenue Net
SalesRevenueNet
18704000
CY2016Q1 us-gaap Gross Profit
GrossProfit
8195000
CY2016Q2 us-gaap Gross Profit
GrossProfit
10578000
CY2016Q3 us-gaap Gross Profit
GrossProfit
11498000
CY2016Q4 us-gaap Gross Profit
GrossProfit
12918000
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
-6126000
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
-4436000
CY2016Q3 us-gaap Net Income Loss
NetIncomeLoss
-4075000
CY2016Q4 us-gaap Net Income Loss
NetIncomeLoss
-6266000
CY2016Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-4.34
CY2016Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-3.12
CY2016Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.80
CY2016Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.37
CY2015Q1 us-gaap Sales Revenue Net
SalesRevenueNet
7055000
CY2015Q2 us-gaap Sales Revenue Net
SalesRevenueNet
8887000
CY2015Q3 us-gaap Sales Revenue Net
SalesRevenueNet
9344000
CY2015Q4 us-gaap Sales Revenue Net
SalesRevenueNet
10854000
CY2015Q1 us-gaap Gross Profit
GrossProfit
3882000
CY2015Q2 us-gaap Gross Profit
GrossProfit
5269000
CY2015Q3 us-gaap Gross Profit
GrossProfit
5596000
CY2015Q4 us-gaap Gross Profit
GrossProfit
6693000
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
-4392000
CY2015Q2 us-gaap Net Income Loss
NetIncomeLoss
-4959000
CY2015Q3 us-gaap Net Income Loss
NetIncomeLoss
-5746000
CY2015Q4 us-gaap Net Income Loss
NetIncomeLoss
-7702000
CY2015Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-3.31
CY2015Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-3.66
CY2015Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-4.07
CY2015Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-5.46

Files In Submission

Name View Source Status
0001564590-17-005767-index-headers.html Edgar Link pending
0001564590-17-005767-index.html Edgar Link pending
0001564590-17-005767.txt Edgar Link pending
0001564590-17-005767-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g2017033118224021855009.jpg Edgar Link pending
g2017033118224052755010.jpg Edgar Link pending
g2017033118224054055011.jpg Edgar Link pending
g2017033118224054955012.jpg Edgar Link pending
g2017033118224102355013.jpg Edgar Link pending
g2017033118224102655014.jpg Edgar Link pending
g2017033118224115755015.jpg Edgar Link pending
g2017033118224116255016.jpg Edgar Link pending
g2017033118224116755017.jpg Edgar Link pending
g2017033118224117255018.jpg Edgar Link pending
g2017033118224117855019.jpg Edgar Link pending
g2017033118224178155020.jpg Edgar Link pending
g2017033118225030555021.jpg Edgar Link pending
irtc-10k_20161231.htm Edgar Link pending
irtc-20161231.xml Edgar Link completed
irtc-20161231.xsd Edgar Link pending
irtc-20161231_cal.xml Edgar Link unprocessable
irtc-20161231_def.xml Edgar Link unprocessable
irtc-20161231_lab.xml Edgar Link unprocessable
irtc-20161231_pre.xml Edgar Link unprocessable
irtc-ex231_778.htm Edgar Link pending
irtc-ex311_8.htm Edgar Link pending
irtc-ex312_9.htm Edgar Link pending
irtc-ex321_6.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending